Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2025 12:58 ET | Source: Bragar Eagel & Squire

SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders

Sensus missed Q2 2025 estimates with revenue down 20.7% to $7.3M, citing fewer unit sales, sending shares down 35% to $3.46 on August 8, 2025.
September 08, 2025 17:22 ET | Source: Bragar Eagel & Squire

SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm

On Aug 7, 2025, Sensus missed Q2 EPS/revenue estimates; sales fell 20.7% Y/Y. Shares dropped 35.32% to $3.46 on Aug 8.
September 04, 2025 08:25 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AVITA Medical, Inc....
August 31, 2025 08:13 ET | Source: Bragar Eagel & Squire

SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm

On August 7, 2025, Sensus missed Q2 estimates with a revenue drop of 20.7%, citing fewer unit sales. Shares fell 35.32% to $3.46 on August 8, 2025.
August 23, 2017 16:01 ET | Source: Sensus Healthcare

Sensus Healthcare to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017

BOCA RATON, Fla., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and...